These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18190639)

  • 1. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer.
    Ramsey S; Lamb GW; Aitchison M; McMillan DC
    BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.
    Lamb GW; McArdle PA; Ramsey S; McNichol AM; Edwards J; Aitchison M; McMillan DC
    BJU Int; 2008 Sep; 102(6):756-61. PubMed ID: 18384626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study.
    Cindolo L; Patard JJ; Chiodini P; Schips L; Ficarra V; Tostain J; de La Taille A; Altieri V; Lobel B; Zigeuner RE; Artibani W; Guillé F; Abbou CC; Salzano L; Gallo C
    Cancer; 2005 Oct; 104(7):1362-71. PubMed ID: 16116599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of the role of inflammation in renal cancer.
    Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
    Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 'Stage, Size, Grade and Necrosis' score is more accurate than the University of California Los Angeles Integrated Staging System for predicting cancer-specific survival in patients with clear cell renal cell carcinoma.
    Ficarra V; Novara G; Galfano A; Brunelli M; Cavalleri S; Martignoni G; Artibani W
    BJU Int; 2009 Jan; 103(2):165-70. PubMed ID: 18782313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.
    Ramsey S; Lamb GW; Aitchison M; McMillan DC
    Br J Cancer; 2006 Oct; 95(8):1076-80. PubMed ID: 17003778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma.
    Johnson TV; Abbasi A; Owen-Smith A; Young A; Ogan K; Pattaras J; Nieh P; Marshall FF; Master VA
    J Urol; 2010 Feb; 183(2):480-5. PubMed ID: 20006861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score.
    Iimura Y; Saito K; Fujii Y; Kumagai J; Kawakami S; Komai Y; Yonese J; Fukui I; Kihara K
    J Urol; 2009 Mar; 181(3):1004-12; discussion 1012. PubMed ID: 19150550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.
    Lamb GW; Aitchison M; Ramsey S; Housley SL; McMillan DC
    Br J Cancer; 2012 Jan; 106(2):279-83. PubMed ID: 22166802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the current prognostic models for nonmetastatic renal cell carcinoma after nephrectomy in Chinese population: a 15-year single center experience.
    Liu Z; Lv J; Ding K; Fu Q; Cao Q; Wang F
    Int J Urol; 2009 Mar; 16(3):268-73. PubMed ID: 19087209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer.
    Ramsey S; Lamb GW; Aitchison M; Graham J; McMillan DC
    Cancer; 2007 Jan; 109(2):205-12. PubMed ID: 17149754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the Mayo Clinic cancer specific survival score in a Japanese series of clear cell renal cell carcinoma.
    Fujii Y; Saito K; Iimura Y; Sakai Y; Koga F; Kawakami S; Kumagai J; Kihara K
    J Urol; 2008 Oct; 180(4):1290-5; discussion 1295-6. PubMed ID: 18707704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
    Bigot P; Lughezzani G; Karakiewicz P; Perrotte P; Rioux-Leclercq N; Catros-Quemener V; Bouet F; Moulinoux JP; Cipolla B; Patard JJ
    J Urol; 2010 Feb; 183(2):486-91. PubMed ID: 20006872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The longitudinal relationship between the systemic inflammatory response, circulating T-lymphocytes, interleukin-6 and -10 in patients undergoing immunotherapy for metastatic renal cancer.
    Ramsey S; Aitchison M; Graham J; McMillan DC
    BJU Int; 2008 Jul; 102(1):125-9. PubMed ID: 18336617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammatory response predicts survival following curative resection of colorectal cancer.
    McMillan DC; Canna K; McArdle CS
    Br J Surg; 2003 Feb; 90(2):215-9. PubMed ID: 12555298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of thrombocytosis and C-reactive protein elevation on the prognosis for patients with renal cell carcinoma.
    Ito K; Asano T; Yoshii H; Satoh A; Sumitomo M; Hayakawa M
    Int J Urol; 2006 Nov; 13(11):1365-70. PubMed ID: 17083384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
    Karakiewicz PI; Hutterer GC; Trinh QD; Jeldres C; Perrotte P; Gallina A; Tostain J; Patard JJ
    Cancer; 2007 Sep; 110(6):1241-7. PubMed ID: 17639589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.